SB 221
Alternative Names: SB-221; TensostatLatest Information Update: 09 Sep 2017
At a glance
- Originator SunTen Phytotech
- Developer Lumosa Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Cardiovascular disorders
Highest Development Phases
- Discontinued Cardiovascular disorders; Dyslipidaemias; Essential hypertension
Most Recent Events
- 08 Sep 2017 Discontinued - Phase-II for Cardiovascular disorders in Taiwan (PO)
- 08 Sep 2017 Discontinued - Phase-II for Dyslipidaemias in Taiwan (PO)
- 08 Sep 2017 Discontinued - Phase-II for Essential hypertension in Taiwan (PO)